Vaccine hesitancy has always been an issue, but it seems to have grown since the pandemic and covid vaccines. While there was a high compliance rate when the vaccine was first available, the numbers have dropped for boosters. Around 19.4 million have received the updated bivalent booster, which provides the best protection against the variants, which continue to circulate. And of course, there are other diseases beyond covid, both now and in the future, for which vaccines provide effective protection. We discuss how behavioral science can impact the healthcare challenge of vaccine hesitancy.
A conversation with Jacob Braude, Principal of ZS
Vaccine hesitancy has always been an issue, but it seems to have grown since the pandemic and covid vaccines. While there was a high compliance rate when the vaccine was first available, the numbers have dropped for boosters. Around 19.4 million have received the updated bivalent booster, which provides the best protection against the variants, which continue to circulate. And of course, there are other diseases beyond covid, both now and in the future, for which vaccines provide effective protection. We discuss how behavioral science can impact the healthcare challenge of vaccine hesitancy.
A conversation with Jacob Braude, Principal of ZS